Vital Farms, Inc. $VITL Stock Holdings Lifted by Freedom Investment Management Inc.

Key Points

• Freedom Investment Management Inc. increased its position in Vital Farms by 41.8% during Q1, owning approximately 0.06% of the company valued at $786,000.
• Vital Farms reported $0.36 EPS for the last quarter, exceeding estimates by $0.09, and achieved a 25.4% year-over-year revenue growth.
• Analysts have a consensus Buy rating for Vital Farms, with price targets ranging from $48.20 to $60.00, reflecting optimism about the company's stock performance.

Freedom Investment Management Inc. raised its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 41.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,782 shares of the company's stock after purchasing an additional 7,603 shares during the quarter. Freedom Investment Management Inc. owned approximately 0.06% of Vital Farms worth $786,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of VITL. Caitong International Asset Management Co. Ltd grew its stake in Vital Farms by 20,650.0% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock valued at $51,000 after purchasing an additional 1,652 shares in the last quarter. US Bancorp DE lifted its position in shares of Vital Farms by 36.2% in the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock worth $59,000 after buying an additional 513 shares during the last quarter. CWM LLC lifted its position in shares of Vital Farms by 43.2% in the first quarter. CWM LLC now owns 2,154 shares of the company's stock worth $66,000 after buying an additional 650 shares during the last quarter. Union Bancaire Privee UBP SA acquired a new stake in shares of Vital Farms in the first quarter worth about $112,000. Finally, Hanson & Doremus Investment Management acquired a new stake in shares of Vital Farms in the first quarter worth about $130,000. Hedge funds and other institutional investors own 98.59% of the company's stock.

Vital Farms Price Performance

NASDAQ VITL opened at $51.70 on Tuesday. Vital Farms, Inc. has a twelve month low of $27.91 and a twelve month high of $52.63. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.10 and a current ratio of 2.48. The stock has a market capitalization of $2.31 billion, a PE ratio of 46.16 and a beta of 0.94. The stock has a 50-day simple moving average of $40.23 and a 200 day simple moving average of $35.43.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.09. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%.The business had revenue of $184.77 million during the quarter, compared to analysts' expectations of $170.28 million. During the same quarter in the previous year, the firm earned $0.36 EPS. The firm's revenue was up 25.4% compared to the same quarter last year. Vital Farms has set its FY 2025 guidance at EPS. Research analysts anticipate that Vital Farms, Inc. will post 1.11 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Russell Diez-Canseco sold 16,700 shares of the business's stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $46.11, for a total transaction of $770,037.00. Following the completion of the transaction, the chief executive officer owned 702,476 shares of the company's stock, valued at approximately $32,391,168.36. The trade was a 2.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Matthew Ohayer sold 30,000 shares of the company's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $39.17, for a total value of $1,175,100.00. Following the completion of the transaction, the insider directly owned 6,858,890 shares of the company's stock, valued at approximately $268,662,721.30. This trade represents a 0.44% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 99,105 shares of company stock worth $3,896,696 over the last quarter. 21.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have weighed in on VITL shares. DA Davidson boosted their price target on Vital Farms from $51.00 to $52.00 and gave the stock a "buy" rating in a research report on Monday, August 11th. Lake Street Capital set a $60.00 price target on Vital Farms and gave the stock a "buy" rating in a research report on Friday, August 8th. Mizuho boosted their price target on Vital Farms from $45.00 to $53.00 and gave the stock an "outperform" rating in a research report on Monday, August 11th. BMO Capital Markets reaffirmed an "outperform" rating on shares of Vital Farms in a research report on Friday, August 8th. Finally, Stifel Nicolaus boosted their price target on Vital Farms from $44.00 to $48.00 and gave the stock a "buy" rating in a research report on Friday, August 8th. Eleven analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Vital Farms has an average rating of "Buy" and a consensus price target of $48.20.

Vital Farms Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.